Wockhardt Limited, a pharmaceutical and biotechnology firm, produces and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines globally, with operations in India, the United States, the United Kingdom, Ireland, Mexico, and Russia. The company focuses on developing various molecules, particularly in the field of infectious diseases, including WCK 5222, WCK 4282, WCK 4873, WCK 771, WCK 2349, and WCK 6777. In addition to its biopharmaceutical products such as Glaritus, Wosulin, Wepox, and Biovac-B, Wockhardt Limited offers contract manufacturing services for sterile injectables, lyophilization, and other dosage forms, along with research services. Established in 1967, the company is headquartered in Mumbai, India, and operates as a subsidiary of Themisto Trustee Company Private Limited.
Wockhardt Limited
- 1,384.00 -52.50(-3.65%) 1,382.75 -56.60(-3.93%)
Live Wockhardt Limited Share Price Chart
Wockhardt Limited Share Performance
| Today's Low | Today's High | |
|---|---|---|
| 1,364.70 1,367.40 | 1,428.80 1430.00 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 421.00 (14-Feb-2024) 435.15 (15-Feb-2024) | 1,679.90 (06-Feb-2025) 1,678.60 (06-Feb-2025) |
- Open
- 1,405.00 1,429.95
- Previous Close
- 1,436.50 1,439.35
- Volume
- 5.49
- Total Traded value
- 75.83 (Lakhs)
- Upper circuit
- 1,508.30 558.60
- Lower circuit
- 1,364.70 372.40
Wockhardt Limited Share Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 2,059 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 1,385.15 | 2,059.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 2,059 |
Wockhardt Limited Share Fundamentals
| Market Cap: | 224.86 Cr |
| PE Ratio (TTM): | -126.16 |
| PB Ratio: | 12.73 |
| Industry P/E: | 0.00 |
| Debt to Equity: | 0.00 |
| ROE: | -10.08 |
| EPS (TTM): | -10.96 |
| Book Value: | 102.36 |
| Face Value: | 5.00 |
Wockhardt Limited Stock Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 260.00 Cr | 251.00 Cr | 291.00 Cr | 282.00 Cr | 258.00 Cr |
| Profit | -107.00 Cr | -115.00 Cr | -299.00 Cr | -55.00 Cr | -75.00 Cr |
| Expense | 373.00 Cr | 358.00 Cr | 424.00 Cr | 355.00 Cr | 352.00 Cr |
| Comprehensive income | -107.00 Cr | -114.00 Cr | -294.00 Cr | -55.00 Cr | -75.00 Cr |
| EPS | -7.39 | -8.01 | -20.80 | -3.81 | -5.17 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Wockhardt Limited | Feb, 2000 | Pharmaceuticals Pharmaceuticals | WOCKPHARMA WOCKPHARMA |
Wockhardt Limited Stock Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Wockhardt Limited Share FAQ's
What is the range of today's stock performance for Wockhardt Limited?
Today's stock performance witnessed a fluctuation from a minimum of 1,364.70 on the NSE (National Stock Exchange) to a maximum of 1,428.80. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,367.40 to a high of 1,430.00.
What are the 52-week low and high values for Wockhardt Limited?
The stock's performance over the past 52 weeks reveals a low of 421.00 (occurred on 14-Feb-2024) and a high of 1,679.90 (achieved on 06-Feb-2025) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 435.15 (on 15-Feb-2024), and the 52-week high is 1,678.60 (on 06-Feb-2025).
What was the opening and previous closing prices for Wockhardt Limited?
The stock's performance over the past 52 weeks reveals a low of 421.00 (occurred on 14-Feb-2024) and a high of 1,679.90 (achieved on 06-Feb-2025) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 435.15 (on 15-Feb-2024), and the 52-week high is 1,678.60 (on 06-Feb-2025).
What is the total volume and traded value for Wockhardt Limited for the day?
The total volume is 5, and the total traded value is 75.83 ( Lakhs).
What are the upper and lower circuit limits for Wockhardt Limited?
The upper circuit limit is 1,508.30, and the lower circuit limit is 1,364.70.
What is the market cap and PE ratio for Wockhardt Limited?
The market cap is 224.86 Cr, and the PE ratio (TTM) is 0.00.
What is the PB ratio, industry P/E, and debt to equity ratio for Wockhardt Limited?
The PB ratio is 13.52, industry P/E is 0.00 , and the debt to equity ratio is 0.00.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Wockhardt Limited?
ROE is -10.08, EPS is -10.96, book value is 102.36
What are the revenue and profit figures for the latest quarter and previous quarters for Wockhardt Limited?
In Sep 2023, Revenue is 2600000000.00, and Profit is -1070000000.00. In Jun 2023, Revenue is 2510000000.00, and Profit is -1150000000.00.
When was Wockhardt Limited listed, and what industry does it belong to?
The company, Wockhardt Limited, was listed in Feb 2000 and belongs to the Pharmaceuticals industry. Its NSE symbol is WOCKPHARMA.
What is the current shareholding pattern of the Wockhardt Limited?
As of latest available update, promoters hold 55.14%, the public holds 44.86%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 39
- Threads
- 242
